Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Yoko Kado, BS, Fumiaki Kitazawa, MS, Masayuki Tsujimoto, PhD, Shin-ichi Fuchida, MD PhD, Akira Okano, MD PhD, Mayumi Hatsuse, MD, Satoshi Murakami, MD, Kumi Ueda, BS, Takatoshi Kokufu, BS, Shoichi Ozawa, Natsuko Ito, Satoe Morishita, Tetsuya Takada, BS, Tetsuya Minegaki, PhD, Kohshi Nishiguchi, PhD, Eishi Ashihara, MD PhD, Chihiro Shimazaki, MD PhD

Blood (2015) 126 (23): 3700.

https://doi.org/10.1182/blood.V126.23.3700.3700

Published: 2015

Journal Articles

Expression of Major Histocompatibility Complex Class I-Related Chain (MIC) on Fresh and Cloned Myeloma Cells.

Masashi Okamoto, Tohru Inaba, Sonoko Nakano, Kyoko Namura, Noriko Yamada, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Naoya Ochiai, Thomas Spies, Chihiro Shimazaki

Blood (2004) 104 (11): 2465.

https://doi.org/10.1182/blood.V104.11.2465.2465

Published: 2004

Journal Articles

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro

Naoya Ochiai, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Masashi Okamoto, Eishi Ashihara, Tohru Inaba, Naohisa Fujita, Hiroaki Matsubara, Chihiro Shimazaki

Blood (2003) 102 (9): 3349–3353.

https://doi.org/10.1182/blood-2003-03-0851

Published: 2003

Journal Articles

Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

Chihiro Shimazaki, Naoya Ochiai, Ryo Uchida, Akira Okano, Shin-ichi Fuchida, Eishi Ashihara, Tohru Inaba, Naohisa Fujita, Etsuko Maruya, Masao Nakagawa

Blood (2003) 101 (8): 3334–3336.

https://doi.org/10.1182/blood-2002-09-2883

Published: 2003

Journal Articles

Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors

Takafumi Kimura, Hideaki Sakabe, Shigeatsu Tanimukai, Tatsuo Abe, Yoji Urata, Kiyoshi Yasukawa, Akira Okano, Tetsuya Taga, Haruo Sugiyama, Tadamitsu Kishimoto, Yoshiaki Sonoda

Blood (1997) 90 (12): 4767–4778.

https://doi.org/10.1182/blood.V90.12.4767

Published: 1997

NARROW

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Expression of Major Histocompatibility Complex Class I-Related Chain (MIC) on Fresh and Cloned Myeloma Cells.

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro

Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors

Email alerts

ASH Publications

American Society of Hematology

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Expression of Major Histocompatibility Complex Class I-Related Chain (MIC) on Fresh and Cloned Myeloma Cells.

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro

Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only